HealthNotableSingle-source
5.3
Hanmi Pharm enters 3.2 trillion won licensing agreement with Genentech for obesity drug candidate
Yonhap ENLO·KR · CH·3 days ago
The White House is preparing to announce new negotiated drug pricing agreements with biotechnology companies. The specific terms, participating firms, and impact on pharmaceutical revenue remain unconfirmed pending the official release.
Locations
Entities